The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men

被引:0
|
作者
Tomohiro Matsuo
Yasuyoshi Miyata
Katsura Kakoki
Miki Yuzuriha
Akihiro Asai
Kojiro Ohba
Hideki Sakai
机构
[1] Nagasaki University Graduate School of Biochemical Sciences,Department of Urology
来源
BMC Urology | / 16卷
关键词
Mirabegron; Elderly male; Overactive bladder; α1-adrenergic blockers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Rezum Water Vapour Thermal Therapy for Treatment of Lower Urinary Tract Symptoms: A Prospective Single-Centre Analysis
    Barbour, F.
    Breish, M.
    Jenkins, B.
    Sahadevan, K.
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [42] Alpha-Blocker Treatment Response in Men With Lower Urinary Tract Symptoms Based on Sympathetic Activity: Prospective, Multicenter, Open-Labeled, Observational Study
    Park, Sung Gon
    Chung, Byung Ha
    Lee, Sung Won
    Park, Jong Kwan
    Park, Kwangsung
    Cheon, Jun
    Lee, Kyung Seop
    Kim, Hyung-Jee
    Seong, Do-Hwan
    Oh, Seung-June
    Kim, Sae Woong
    Lee, Ji Youl
    Choo, Seol Ho
    Choi, Jong Bo
    INTERNATIONAL NEUROUROLOGY JOURNAL, 2015, 19 (02) : 107 - 112
  • [43] Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study
    Yokoyama, Osamu
    Tsujimura, Akira
    Akino, Hironobu
    Segawa, Naoki
    Tamada, Satoshi
    Oguchi, Naoki
    Kitagawa, Yasuhide
    Tsuji, Hidenori
    Watanabe, Akihiko
    Inamoto, Teruo
    Shimizu, Nobutaka
    Fujiuchi, Yasuyoshi
    Katsuoka, Yoji
    Azuma, Haruhito
    Matsuda, Tadashi
    Namiki, Mikio
    Uemura, Hirotsugu
    Okuyama, Akihiko
    Nonomura, Norio
    Fuse, Hideki
    Nakatani, Tatsuya
    WORLD JOURNAL OF UROLOGY, 2015, 33 (05) : 659 - 667
  • [44] Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study
    Osamu Yokoyama
    Akira Tsujimura
    Hironobu Akino
    Naoki Segawa
    Satoshi Tamada
    Naoki Oguchi
    Yasuhide Kitagawa
    Hidenori Tsuji
    Akihiko Watanabe
    Teruo Inamoto
    Nobutaka Shimizu
    Yasuyoshi Fujiuchi
    Yoji Katsuoka
    Haruhito Azuma
    Tadashi Matsuda
    Mikio Namiki
    Hirotsugu Uemura
    Akihiko Okuyama
    Norio Nonomura
    Hideki Fuse
    Tatsuya Nakatani
    World Journal of Urology, 2015, 33 : 659 - 667
  • [45] Role of the newer alpha1-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms
    Lowe, FC
    CLINICAL THERAPEUTICS, 2004, 26 (11) : 1701 - 1713
  • [46] A prospective, randomized, open-label, parallel trial comparing the efficacy of α-blocker or 5α-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Lee, Kwang Suk
    Yoo, Jeong Woo
    Kim, Dae Ho
    Jeon, Soyoung
    Yang, Juyeon
    Chung, Byung Ha
    Koo, Kyo Chul
    PROSTATE, 2024, 84 (04): : 403 - 413
  • [47] Change in parameters before and after alpha-1-blocker therapy for men with lower urinary tract symptoms using color Doppler ultrasound urodynamics: Possible application for prediction of clinical outcome
    Watanabe, Y
    Yokoyama, T
    Ozawa, H
    Nishiguchi, J
    Nose, H
    Kumon, H
    UROLOGIA INTERNATIONALIS, 2004, 73 (03) : 252 - 257
  • [48] Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis
    Kallidonis, Panagiotis
    Adamou, Constantinos
    Kotsiris, Dimitrios
    Ntasiotis, Panteleimon
    Verze, Paolo
    Athanasopoulos, Anastasios
    EUROPEAN UROLOGY FOCUS, 2020, 6 (03): : 537 - 558
  • [49] Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis
    Kim, Hyun Jung
    Sun, Hwa Yeon
    Choi, Hoon
    Park, Jae Young
    Bae, Jae Hyun
    Doo, Seung Whan
    Yang, Won Jae
    Song, Yun Seob
    Ko, Young Myoung
    Kim, Jae Heon
    PLOS ONE, 2017, 12 (01):
  • [50] Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study
    Lee, J. Y.
    Cho, S. Y.
    Oh, C. Y.
    Ha, U. S.
    Lee, S. H.
    Park, S. Y.
    Moon, H. S.
    Lee, S. W.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2011, 23 (06) : 249 - 256